Niklas Mattsson-Carlgren
161 – 170 of 229
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Relevance of biomarkers across different neurodegenerative
- Contribution to journal › Scientific review
-
Mark
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- Contribution to journal › Article
-
Mark
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease
- Contribution to journal › Article
-
Mark
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
- Contribution to journal › Article
-
Mark
Differential expression of cerebrospinal fluid neuroinflammatory mediators depending on osteoarthritis pain phenotype
- Contribution to journal › Article
- 2019
-
Mark
Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients
- Contribution to journal › Article
-
Mark
Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest
- Contribution to journal › Article
-
Mark
Biomarkers for tau pathology
- Contribution to journal › Article
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
- Contribution to journal › Article
